Efficacy of Ecabet Sodium for <i>Helicobacter pylori</i> Eradication with Sequential Therapy

Seol So; Ji Yong Ahn; Hee Kyong Na; Kee Wook Jung; Jeong Hoon Lee; Do Hoon Kim; Kee Don Choi; Ho June Song; Gin Hyug Lee; Hwoon-Yong Jung

doi:10.7704/kjhugr.2019.19.1.78

Search: Korean J Helicobacter Up Gastrointest Res Search

CLOSE

Korean J Helicobacter Up Gastrointest Res > Volume 19(1); 2019 > Article

순차치료에 병합 투여된 Ecabet Sodium이 Helicobacter pylori 제균에 미치는 효과

Correction

The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2019;19(1):78.

Published online: March 10, 2019

DOI: https://doi.org/10.7704/kjhugr.2019.19.1.78

순차치료에 병합 투여된 Ecabet Sodium이 Helicobacter pylori 제균에 미치는 효과

소설, 안지용

, 나희경, 정기욱, 이정훈, 김도훈, 최기돈, 송호준, 이진혁, 정훈용

울산대학교 의과대학 서울아산병원 소화기내과

Efficacy of Ecabet Sodium for Helicobacter pylori Eradication with Sequential Therapy

Seol So, Ji Yong Ahn

, Hee Kyong Na, Kee Wook Jung, Jeong Hoon Lee, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee, Hwoon-Yong Jung

Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Corresponding author: Ji Yong Ahn Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea
Tel: +82-2-3010-5667, Fax: +82-2-476-0824, E-mail: ji110@hanmail.net

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

This corrects the article "Efficacy of Ecabet Sodium for Helicobacter pylori Eradication with Sequential Therapy" on page 180.

대한상부위장관ㆍ헬리코박터학회지에 게재된 위 논문에서 사사 번호에 오류가 있어 정정합니다.

This correction is being published to correct the grant number in above article.

Before correction

This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI15C1234).

After correction

TOOLS

Share :

METRICS

0 Crossref
3,006 View
41 Download

Related articles in Korean J Helicobacter Up Gastrointest Res

Can Helicobacter pylori Infection Reduce the Efficacy of Cancer Immunotherapy?2023 December;23(4)

Comparison of Helicobacter pylori Eradication Rates Using Standard Triple Therapy and Sequential Therapy2023 December;23(4)

Types of 23S Ribosomal RNA Point Mutations Affecting Helicobacter pylori Eradication Rates in Clarithromycin-Based Triple Therapy2023 December;23(4)

Does Types of 23S-Ribosomal RNA Point Mutations Affect Helicobacter pylori Eradication Rate in Clarithromycin-Based Triple Therapy?2023 December;23(4)

Vonoprazan-based Dual and Triple Therapy for Helicobacter pylori Eradication2023 September;23(3)

Editorial Office: Lotte Gold Rose II Room 917, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-717-5543 Fax: +82-2-565-9947 E-mail: helicojournal@smileml.com